Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Byetta and Glucophage in Chinese PCOS Patients
NCT04969627Phase 4Completed
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of exenatide in polycystic ovary syndrome (PCOS). Started Jan 2021; status: completed.
02
Drugs
exenatide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04969627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04969627.